NEUROCRINE BIOSCIENCES INC (NBIX) › Shareholders' EquityNEUROCRINE BIOSCIENCES INC (NBIX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2008: $36.77M2009: $3.95M2010: $19.34M2011: $60.08M2012: $154.37M2013: $120.41M2014: $208.70M2015: $424.45M2016: $314.88M2017: $372.20M2018: $480.80M2019: $636.90M2020: $1.13B2021: $1.37B2022: $1.71B2023: $2.23B2024: $2.59B2025: $3.25B$3.25B2008Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$3.25B+25.6%2024$2.59B+16.0%2023$2.23B+30.7%2022$1.71B+24.3%2021$1.37B+22.0%2020$1.13B+76.8%2019$636.90M+32.5%2018$480.80M+29.2%2017$372.20M+18.2%2016$314.88M-25.8%2015$424.45M+103.4%2014$208.70M+73.3%2013$120.41M-22.0%2012$154.37M+156.9%2011$60.08M+210.6%2010$19.34M+389.3%2009$3.95M-89.2%2008$36.77M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share